Notification in terms of S122(3) if the Companies Act and section 3.83(b) of the JSE Listings Requirements ADVANCED HEALTH LIMITED (Incorporated in the Republic of South Africa) (Registration number 2013/059246/06) (“the Company” or “Advanced Health”) ISIN Code: ZAE000189049 JSE Code: AVL NOTIFICATION IN TERMS OF SECTION 122(3) OF THE COMPANIES ACT AND SECTION 3.83(B) OF THE JSE LISTINGS REQUIREMENTS In accordance with section 122(3)(b) of the Companies Act, 71 of 2008 ("the Act"), and section 3.83(b) of the JSE Limited Listings Requirements, holders of ordinary shares in the Company are advised Sanlam Investment Management Proprietary Limited (acting as agent of its clients), have, as a result of the Advanced Health Rights Offer, acquired and disposed of beneficial interests in ordinary shares of the Company ("the securities"), such that its shareholding in the securities of the Company currently amounts to 5.93% of the total number of shares in issue, as at 7 April 2021. Advanced Health hereby confirms that it has received the required notices from the above named parties in terms of section 122(3)(a) of the Act, and that it has filed the required notices with the Takeover Regulation Panel. Johannesburg 7 April 2021 Designated Advisor Grindrod Bank Limited Date: 07-04-2021 04:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.